myelitis

One participant in the AstraZeneca clinical trial in Britain developed symptoms consistent with transverse myelitis, a rare neurological disorder characterized by inflammation of the spinal cord, but the diagnosis was not confirmed.

The crazy thing, though, is that the way that the FDA found out about the case of transverse myelitis was the same way the public found out, which was through a leaked story to, I think, STAT News.

“In the history of vaccine development, cases of myelitis are not especially surprising,” says Carlos Pardo-Villamizar, a clinical neurologist and director of the Johns Hopkins Transverse Myelitis Center.

Witness the frightful itching sometimes experienced during the progress of chronic myelitis.

Affections of the Spinal Cord are extremely rare, but paraplegia from myelitis has been observed.

Examination of the spinal (lumbar) cord showed acute disseminated myelitis.

The symptoms are mainly referable to the nervous system, causing a transverse myelitis and paraplegia.

In another group of cases myelitis is a result of the action of organisms or their toxins.